Triple Receptor Agonist
Synthetic triple-receptor agonist peptide. Investigated in vitro for GIP, GLP-1, and glucagon receptor binding and downstream signaling in cell-based assays.
For laboratory research use only. Not for human consumption. Not approved by the FDA for human or veterinary use.
Retatrutide is a synthetic peptide characterized as a triple agonist of the GIP, GLP-1, and glucagon receptors. In laboratory settings it is used to study receptor-binding affinity, cAMP signaling, and receptor-internalization kinetics in transfected cell lines. Identity and purity are confirmed by HPLC and mass spectrometry on every lot.